The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
1-[4-[3-chloro-4-[(3-fluorophenyl)methoxy]anilino]-8,9-dihydro-7H-pyrimido[5,4-h][1,5]benzoxazepin-6-yl]-4-morpholino-but-2-en-1-one ID: ALA4632500
PubChem CID: 78322608
Max Phase: Preclinical
Molecular Formula: C32H31ClFN5O4
Molecular Weight: 604.08
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: O=C(/C=C/CN1CCOCC1)N1CCCOc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3cc21
Standard InChI: InChI=1S/C32H31ClFN5O4/c33-26-17-24(7-8-29(26)43-20-22-4-1-5-23(34)16-22)37-32-25-18-28-30(19-27(25)35-21-36-32)42-13-3-10-39(28)31(40)6-2-9-38-11-14-41-15-12-38/h1-2,4-8,16-19,21H,3,9-15,20H2,(H,35,36,37)/b6-2+
Standard InChI Key: ZIBGWVMVDVXMIC-QHHAFSJGSA-N
Molfile:
RDKit 2D
43 48 0 0 0 0 0 0 0 0999 V2000
23.0424 -16.6007 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.0415 -14.9634 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.7504 -15.3711 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.7496 -16.1934 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.4608 -16.6014 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
25.1732 -16.1923 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.1700 -15.3669 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
24.4583 -14.9585 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.4555 -14.1372 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
25.1659 -13.7262 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.8784 -14.1377 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.5884 -13.7274 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.5860 -12.9052 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.8678 -12.4951 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.1608 -12.9119 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.3014 -14.1339 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
27.2959 -12.4891 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
28.0097 -12.8984 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.7155 -12.4824 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.4262 -12.8959 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.1356 -12.4805 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.1322 -11.6583 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.4134 -11.2532 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.7070 -11.6668 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.8492 -12.8902 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
22.3414 -15.3739 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.3381 -16.1934 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.6927 -16.7075 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
21.6971 -14.8584 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.8907 -16.5272 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.8930 -15.0416 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.5370 -15.7850 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.6927 -14.0408 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.3982 -13.6285 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
20.9828 -13.6360 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.2773 -14.0484 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.5674 -13.6435 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.8619 -14.0559 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.1550 -13.6499 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.4516 -14.0588 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.4517 -14.8763 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
18.1614 -15.2833 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.8710 -14.8728 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27 1 1 0
1 4 2 0
3 2 2 0
2 26 1 0
3 4 1 0
4 5 1 0
5 6 2 0
6 7 1 0
7 8 2 0
8 3 1 0
8 9 1 0
9 10 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 10 1 0
12 16 1 0
13 17 1 0
17 18 1 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 19 1 0
21 25 1 0
26 27 2 0
27 28 1 0
26 29 1 0
28 30 1 0
29 31 1 0
30 32 1 0
31 32 1 0
29 33 1 0
33 34 2 0
33 35 1 0
35 36 2 0
36 37 1 0
37 38 1 0
38 39 1 0
38 43 1 0
39 40 1 0
40 41 1 0
41 42 1 0
42 43 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 604.08Molecular Weight (Monoisotopic): 603.2049AlogP: 5.75#Rotatable Bonds: 8Polar Surface Area: 89.05Molecular Species: NEUTRALHBA: 8HBD: 1#RO5 Violations: 2HBA (Lipinski): 9HBD (Lipinski): 1#RO5 Violations (Lipinski): 2CX Acidic pKa: ┄CX Basic pKa: 6.23CX LogP: 4.96CX LogD: 4.93Aromatic Rings: 4Heavy Atoms: 43QED Weighted: 0.25Np Likeness Score: -1.51
References 1. Sun M, Jia J, Sun H, Wang F.. (2020) Design and synthesis of a novel class EGFR/HER2 dual inhibitors containing tricyclic oxazine fused quinazolines scaffold., 30 (9): [PMID:32139324 ] [10.1016/j.bmcl.2020.127045 ]